POMZEVRA
DEAD

Add to watchlist:

No watchlists yet
View on USPTO

POMZEVRA Trademark

Serial Number: 97909408

POMZEVRA is a trademark filed by REGENERON PHARMACEUTICALS, INC. on April 26, 2023. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

REGENERON PHARMACEUTICALS, INC. (431 trademarks)

Tarrytown, NY 10591

Entity Type: 03

Trademark Details

Filing Date

April 26, 2023

Registration Date

Not Registered

Published for Opposition

December 31, 2024

Goods & Services

Pharmaceutical preparations for the treatment of hematological, gastrointestinal, neuromuscular, muscular, cardiovascular, metabolic, immunological, inflammatory, oncological, ophthalmological, neurological, musculoskeletal, bone, connective tissue, dermatological, infectious, autoimmune, nephrological, hepatological, allergic, genetic, respiratory, viral diseases and disorders, and for the treatment of pain

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Sep 29, 2025 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Sep 29, 2025 ABN6
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jun 30, 2025 TCCA
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Jun 30, 2025 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Jun 30, 2025 COAR
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Feb 25, 2025 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 31, 2024 NPUB
PUBLISHED FOR OPPOSITION
Dec 31, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 25, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 6, 2024 CNSA
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Oct 28, 2024 RCCK
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Dec 8, 2023 GNS3
LETTER OF SUSPENSION E-MAILED
Dec 8, 2023 GNSL
SUSPENSION LETTER WRITTEN
Dec 8, 2023 CNSL
ASSIGNED TO EXAMINER
Nov 22, 2023 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 24, 2023 NWOS
NEW APPLICATION ENTERED
May 1, 2023 NWAP